<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic SyndromesJohn S. Welch, Timothy J. Ley, Keith Stockerl‐Goldstein et al.|New England Journal of Medicine|2016Cited by 783
First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantationRizwan Romee, Jeffrey S. Miller, Sarah Cooley et al.|Blood|2018Cited by 406
Severe Cytokine-Release Syndrome after T Cell–Replete Peripheral Blood Haploidentical Donor Transplantation Is Associated with Poor Survival and Anti–IL-6 Therapy Is Safe and Well ToleratedRamzi Abboud, Rizwan Romee, Jesse Keller et al.|Biology of Blood and Marrow Transplantation|2016Cited by 164
Multidimensional Analyses of Donor Memory-Like NK Cells Reveal New Associations with Response after Adoptive Immunotherapy for LeukemiaMelissa M. Berrien-Elliott, Todd A. Fehniger, Amanda F. Cashen et al.|Cancer Discovery|2020Cited by 146
Mutation Clearance after Transplantation for Myelodysplastic SyndromeEric J. Duncavage, Matthew J. Walter, Meagan A. Jacoby et al.|New England Journal of Medicine|2018Cited by 121